Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 2/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12378007 | 0.97 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2TSHRTDP1CYP3A4 | |
| SCHEMBL29378528 | 0.97 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2TSHRTDP1CYP3A4 | |
| Phosphine SCHEMBL22361930 | 0.97 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2TSHRTDP1CYP3A4 | |
| SCHEMBL13317292 | 0.97 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2TSHRTDP1CYP3A4 | |
| SCHEMBL9352887 | 0.91 | ALDH1A1 (0.81) | ALDH1A1SMN1; SMN2TSHRTDP1CYP3A4 | |
| SCHEMBL5608812 | 0.86 | ALDH1A1 (0.74) | ALDH1A1SMN1; SMN2TSHRTDP1CYP3A4 | |
| SCHEMBL7188789 | 0.86 | ALDH1A1 (0.67) | ALDH1A1SMN1; SMN2TSHRTDP1CYP3A4 | |
| SCHEMBL2672668 | 0.84 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2TSHRTDP1CYP3A4 | |
| SCHEMBL16186449 | 0.84 | ALDH1A1 (0.61) | ALDH1A1SMN1; SMN2TSHRTDP1CYP3A4 | |
| SCHEMBL16186446 | 0.84 | ALDH1A1 (0.71) | ALDH1A1SMN1; SMN2TSHRTDP1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114031639-A | Preparation method of biphosphonate with P-O-C-P structure | 烟台大学 | 2022-02-11 | — | — | CN | claimed |
| CN-103582690-B | A kind of method of preparing core-shell nano and solution thereof | BAYER TECHNOLOGY AND ENGINEERING (SHANGHAI) Co.,Ltd. (CN) | 2016-05-25 | — | — | CN | claimed |
| CN-105358238-A | Multi-channel membrane | BASF SE | 2016-02-24 | — | — | CN | claimed |
| CN-103582690-A | Preparation methods of core-shell nanoparticles and solution thereof | BAYER TECHNOLOGY AND ENGINEERING SHANGHAI CO LTD | 2014-02-12 | — | — | CN | claimed |
| US-7741240-B2 | Transition metal compounds for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-06-22 | — | — | US | claimed |
| EP-1753773-A1 | TRANSITION METAL COMPOUNDS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | ExxonMobil Chemical Patents Inc. (US) | 2007-02-21 | — | — | EP | claimed |
| WO-2005118605-A1 | TRANSITION METAL COMPOUNDS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS, INC. (US) | 2005-12-15 | — | — | WO | claimed |
| CN-114031639-B | Preparation method of biphospide with P-O-C-P structure | 烟台大学 | 2024-07-12 | — | — | CN | disclosed |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| US-11765967-B2 | Highly efficient OLED devices with very short decay times | UDC IRELAND LIMITED (IE) | 2023-09-19 | — | — | US | disclosed |
| CN-111606945-B | Preparation method of compound containing P-O bond or P-S bond | 烟台大学 | 2023-06-20 | — | — | CN | disclosed |
| CN-109863223-B | Preparation of organic functional material | 默克专利有限公司 | 2023-06-20 | — | — | CN | disclosed |
| US-20230026258-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2023-01-26 | — | — | US | disclosed |
| EP-0317208-A2 | Preparation of Diaryl Ethers and Diaryl Sulfides | AMOCO CORPORATION (US) | 1989-05-24 | — | — | EP | disclosed |
| EP-0135938-B1 | PROCESS FOR PRODUCING AROMATIC POLYETHER KETONES AND POLYTHIOETHER KETONES | MITSUBISHI KASEI CORPORATION (JP) | 1988-06-22 | — | — | EP | disclosed |
| US-4707536-A | Catalytic preparation of aromatic polyketone from phosgene and aromatic ether or sulfide | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1987-11-17 | — | — | US | disclosed |
| US-4661581-A | REACTING AROMATIC ETHERS OR THIOETHERS WITH PHOSGENE IN AN APROTIC SOLVENT WITH GROUP 3 METAL HALIDE CATALYST | MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) | 1987-04-28 | — | — | US | disclosed |
| EP-0135938-A2 | Process for producing aromatic polyether ketones and polythioether ketones | MITSUBISHI KASEI CORPORATION (JP) | 1985-04-03 | — | — | EP | disclosed |
| US-4271035-A | CONTAINING A POLYALKYLENE GLYCOL DERIVATIVE | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1981-06-02 | — | — | US | disclosed |
| EP-0008735-A1 | Process for the preparation of diphenyl ether carboxylic acids | BAYER AG (DE) | 1980-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026258-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | ALDH1A1 2588/4885SMN1; SMN2 3047/4885TSHR 1713/4885 |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | ALDH1A1 2588/4885SMN1; SMN2 3047/4885TSHR 1713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.